Sort
25,944 grants matching “neurodegeneration”
Endocannabinoid signaling and aging
$390,151Matthew Simon Gill · Scripps Florida · R01 · FY2014 · AG
Endocannabinoid signaling and aging
$390,151Matthew Simon Gill · Scripps Florida · R01 · FY2012 · AG
Endocannabinoid signaling and aging
$390,151Matthew Simon Gill · Scripps Florida · R01 · FY2011 · AG
Effects of modified erythropoietin on cognition and neuropathology
$390,137Michael P McDonald · University Of Tennessee Health Sci Ctr · R01 · FY2016 · NS
Role of REV-ERB Proteins in Neuroinflammation and Alzheimer's Disease
$390,131Erik Steven Musiek · Washington University · R01 · FY2020 · AG
Murine Transgenic Models of Prion Diseases
$390,106David A Harris · Washington University · R01 · FY2007 · NS
Identifying and leveraging strategies of inherently resilient retinal neurons to treat degeneration
$390,100Philip Raymond Williams · Washington University · R01 · FY2022 · EY
Effects of the Sleep/Wake Cycle on A-Beta, Tau and Spreading
$390,029David M Holtzman · Washington University · P01 · FY2019 · NS
Connecting nuclear functions of Tau with pathology in Alzheimer's disease and other Tauopathies
$390,000Doris Kretzschmar · Oregon Health & Science University · R01 · FY2024 · AG
Small molecule targeting of MLK3 for heart failure
$390,000Burns C Blaxall · Cincinnati Childrens Hosp Med Ctr · R01 · FY2018 · HL
Developing RNA Oligonucleotides to Mitigate Abberant FUS Phase Transition in FTD/ALS
$390,000Lin Guo · Thomas Jefferson University · R01 · FY2024 · NS
Elucidating the Mechanism in the Regulation of RNA-binding Protein Phase Separation
$390,000Lin Guo · Thomas Jefferson University · R35 · FY2022 · GM
Michigan Alzheimer's Disease Core Center
$390,000Henry L Paulson · University Of Michigan At Ann Arbor · P30 · FY2018 · AG
The Role of Adenosine in Retinal Ischemia
$390,000Steven Roth · University Of Chicago · R01 · FY2012 · EY
SLC25A46 mutations cause optic atrophy, axonal neuropathy, and cerebellar neurodegeneration
$390,000Taosheng Huang · Cincinnati Childrens Hosp Med Ctr · R01 · FY2016 · EY
Neurodegeneration and Microvascular Damage in Alzheimer's Disease
$390,000Jarin Hongpaisan · Thomas Jefferson University · R01 · FY2022 · AG
Supplement -- The pathogenic relationship between neuronal activity and C9orf72-linked neurodegeneration
$390,000Aaron Raymond Haeusler · Thomas Jefferson University · RF1 · FY2021 · NS
Relationships Between Brain Tissue Integrity and Self-Care Abilities in Adults with Type 2 Diabetes-Administrative Supplement
$390,000Rajesh Kumar · University Of California Los Angeles · R01 · FY2020 · NR
Atypical TDP43 isoforrms driving neurodegeneration in FTD/ALS
$390,000Sami Barmada · University Of Michigan At Ann Arbor · R01 · FY2022 · NS
Resolving selective vulnerability and disease progression in human Alzheimer's brain via single-cell RNA-seq
$390,000Inma Cobos · University Of California Los Angeles · R01 · FY2018 · AG
Novel serological biomarkers for BBB dysfunction during HIV-1 infection
$390,000Servio Heybert Ramirez · Temple Univ Of The Commonwealth · R01 · FY2016 · NS
Elucidating the Mechanism in the Regulation of RNA-binding Protein Phase Separation
$390,000Lin Guo · Thomas Jefferson University · R35 · FY2024 · GM
Elucidating the Mechanism in the Regulation of RNA-binding Protein Phase Separation
$390,000Lin Guo · Thomas Jefferson University · R35 · FY2021 · GM
Elucidating the Mechanism in the Regulation of RNA-binding Protein Phase Separation
$390,000Lin Guo · Thomas Jefferson University · R35 · FY2020 · GM
Neurodegeneration and Microvascular Damage in Alzheimer's Disease
$390,000Jarin Hongpaisan · Thomas Jefferson University · R01 · FY2021 · AG